Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease

被引:24
作者
Katsunuma, H
Shimizu, T
Ogawa, K
Kubo, H
Ishida, H
Yoshihama, A
机构
[1] Omotemachi Hosp, Tachikawa Med Ctr, Dept Internal Med, Nagoya, Aichi, Japan
[2] Omotemachi Hosp, Tachikawa Med Ctr, Dept Radiol, Nagoya, Aichi, Japan
[3] Kashiwazaki Kosai Hosp, Kashiwazaki, Japan
关键词
aged; Alzheimer's disease; Aniracetam; cerebral infarction; cerebroatrophy; Parkinson's disease; Zopiclone;
D O I
10.1111/j.1440-1819.1998.tb01028.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
For insomniac patients, sleeping drugs are used; in addition, concomitant therapy with other drugs has been tried in an effort to prevent a decrease in the effects due to long-term continuous use. This report presents the results of a study on the sleeping effects in nine aged patients with insomnia associated with cerebrovascular and non-cerebrovascular disorders who received concomitant therapy with Zopiclone and Aniracetam. The treatment in 7/9 cases (78%) was found to be effective, showing more than 50% prolongation of sleeping time, and in two casts (22%) was found to be ineffective. We discuss the mechanism of action referring to the literature.
引用
收藏
页码:198 / 200
页数:3
相关论文
共 5 条
[1]  
HIROSE N, 1993, JPN PHARMACOL THER, V21, P2361
[2]  
IIDA H, 1994, J NUCL MED, V35, P2019
[3]   ZOPICLONE VERSUS NITRAZEPAM - A DOUBLE-BLIND COMPARATIVE-STUDY OF EFFICACY AND TOLERANCE IN ELDERLY PATIENTS WITH CHRONIC INSOMNIA [J].
KLIMM, HD ;
DREYFUS, JF ;
DELMOTTE, M .
SLEEP, 1987, 10 :73-78
[4]   A 3-STATE MODEL OF THE BENZODIAZEPINE RECEPTOR EXPLAINS THE INTERACTIONS BETWEEN THE BENZODIAZEPINE ANTAGONIST RO 15-1788, BENZODIAZEPINE TRANQUILIZERS, BETA-CARBOLINES, AND PHENOBARBITONE [J].
POLC, P ;
BONETTI, EP ;
SCHAFFNER, R ;
HAEFELY, W .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1982, 321 (04) :260-264
[5]  
SASAKI M, 1983, P ZOP S KINM RHON PO